Healthcare >> Analyst Interviews >> September 14, 2009
ALASTAIR MACKAY, Ph.D. joined GARP Research & Securities in 2005. In 2007 and
2008, he garnered respectable rankings in The Wall Street Journal's "Best on the
Street" annual survey of the sell side. As a researcher at Osiris Therapeutics
(1996-2005), Mr. Mackay studied the growth and differentiation of human
mesenchymal stem cells. Before that he was a postdoctoral fellow at the Johns
Hopkins University (1989-1995), where he used "reverse-genetics" to identify the
function of INCENP, an essential protein component of chromosomes. Mr. Mackay
earned his doctorate from the University of Vermont in 1989 by studying
carcinogenesis in asbestos-induced mesotheliomas. Profile
Mr. Mackay: The sectors I cover include medical devices, diagnostics and science
tools.
TWST: What are some of
